1066

Dr Rajeev Garg

Cardiology
30+ Years  experience
MD (MEDICINE), DIP. CARD (NIMS ), DNB (CARDIOLOGY) MNAMS, FACC, FESC, FSCAI
13:30 - 17:00  •  Mon - Sat (Except Wed) English  •  Telugu  •  Hindi

DOCTOR UNAVAILABLE

No Slots Available. Please request a call back

Select Date

    > Loading available days...

Available Slots:

    Overview

    Dr. Rajeev Garg is a highly accomplished Senior Interventional Cardiologist and Heart Failure Specialist with over 30 years of clinical experience in the field of cardiology. He currently serves at Apollo Hospitals, Hyderguda, and has previously led cardiology departments at AWARE Gleneagles Global Hospital and Yashoda Super Speciality Hospital, Hyderabad. A distinguished alumnus with an MD (Medicine), DNB (Cardiology), and Diploma in Cardiology (NIMS), Dr. Garg has performed more than 15,000 angiographies, 5,000 angioplasties, 400 PBMV procedures, and numerous pacemaker and CRT implantations. His expertise spans interventional cardiology, structural heart disease interventions (ASD, PDA, VSD closures, TAVI), heart failure management, and cardiac transplantation. A Fellow of the American College of Cardiology (FACC), European Society of Cardiology (FESC), and Society for Cardiovascular Angiography and Interventions (FSCAI), Dr. Garg has also contributed extensively to clinical trials, research publications, and academic conferences, including serving as National Convener for Heart Failure (CSI 2024–2026) and President of CSI Telangana (2022–2023). Recognized with multiple awards such as the Bhumi Seva Bhushan, Vaidya Shiromani, and Digital Pioneer Award (ACC 2024), Dr. Garg continues to be a leading voice in advancing cardiovascular care in India through research, innovation, and compassionate patient care.

    Apollo Hospitals, Hyderguda
    Apollo Hospitals, 3-5-874/1, Near Old Mla Quarters, Hyderguda, Hyderabad, TS, 500029

    Experience

    30 years in cardiology done more than 15000 angios, 5000 angioplasties, 400 pbmv, 300 pacemaker, 15 crtd, associated with lvad and cardiac transplant patient.

    • Ang 2025: Senior interventional cardiologist & heart failure specilist apollo hospitals (Hyderguda).
    • 2017-2025: Senior interventional cardiologist & hod lenengles global aware hospital hyderabad.
    • 2001-2017: Consultant interventional cardiologist yashoda super speciality hospital.
    • 2000-2001: Dip cardiology resident nims hyderabad under dr. S jai shankar & team.
    • 1999-2000: Registar cardiology durga bai deshmukh hospital (Andhra mahilasaba).
    • 1995-1999: Senior resident cardiology, nims hyderabad under dr b somaraju & team.
    • 1995-1998: Dnb resident cardiology under dr r. Dayasagar rao & team.

    Memberships

    • API, CSI, PCSI, ICIC, IAE, ISH, APSIC

    Awards

    Post :

    • National convener for heart faliure under cardiology society of India (2024-2026).
    • President telangana state CSI 2022-2023.
    • President elect 2021-2022. · hon. Organizing secretary 2019-2020.
    • Joint secretary telangana state CSI 2018-2019.

    Trials :

    • Rivera (Registry of intra venous anticoagulation in the elective an enoxaparin in PCI).
    • Pricipal investigator in incorandil od preparation phase – III trial.
    • Pricipal investigator for indian expericnce for rimonabant in oesity.
    • Co investigator in seepia and shine study: Study of automixoban.
    • Pi in tuxedo study – double blind 5 years study of xtence vs superafle+.
    • Fami (Fragmin in acute myocardial infraction) A double blind placemaker of thrombosis research institue london. · analysis of 12 moths clinical outcomes associated with implantation an unselected real world population with coronary artery.
    • A phase III, randomised, double-blind, placebo-controlled, event-driven study to evaluate the effect of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on the risk of incident heart failure and cardiovascular death in participants with increased risk of developing heart failure (Baxduo prevent-hf).
    • A phase III, randomised, double –blind study to evaluate the effect of balcinrenone / Dapagliflzin, compared with dapagliflozin, on the risk of heart failure and impaired kidney function.

    Awards :

    • Awarded bhuni seva bhushan by Tara sansthan udaipur.
    • Success today excellance award.
    • Agarwal samaj cardiologist of year 2016.
    • Vaidya shiromani 2012.
    • Felicitated by ici/API in ckm connect 17/5/2025.
    • Most tructed cardiologist of hyderabad by bynagia group 6.6.2025.
    • Digital pioneer by America college of cardiology in management of cardiovascular disease 2024.
    • International excelence award by bse 2024.
    • Disease visiting faculty to tctap seol South Korea.

    Certification :

    • MBBS (SEP 1989)
    • MD (MEDICINE) 1992 SEP
    • DNB (JUN 2001) · FSCAI (2014)
    • FACC (2018) · FESC (2018)
    • EUROPEAN SOCIETY OF HTN (2017)

    Research and Publication

    Conference Organised:

    • Conducted heart failure national conference year in heart failure 2025. Recent updates in association with european society of cardiology associate on sept 20, 21 – 2025 at national confrence chairman and scentific convenor.
    • Conducted state level CSI confrence in march 2023.

    Authored Chapters:

    • Top 10 papers in cardiology updated an offical text book of CSI.
    • Management of dyslipedaemia in Young and asymptomatic south east ascian people 2022-2023.
    • On pooed orion 10/11 date (Ascvd count) In text book in cvd, authored by dr h k chopra, dr. Navin C nama and dr jagat narmal timing of mital regursiation treatment in ischemic.
    • Prevalancer of hypertension among pharama centrical sales team a cross sectional study publised in international journal of life science, biotechnology & pharma.

    Publications:

    • A study of silent pericardial effusion in pulmonary tuberculosis: Presented at 43rd annual conference of AP, new delhi-1993.
    • Technical note : Percutaneous closure of pda with custome made coils: Indian journal of radiology and imaging vol:4 4 nov 1996.
    • Qtc dispersion study : Presented at south asian society of atherosclerotic and thrombosis (Sasat) Dec. 96. Bangalore.
    • Incidence of renal artery stenosis in cad: CSI 2001, hyd.
    • Evidence of improved LV function following ptca of infarct related artery: Assessed by RN & Echo: CSI 2001, hyd.
    • Low molecular weight heparin for treatment of acute MI : Fragmin in acute study: Ihj sept – oct 2000 (One of the principal participants).
    • Analysis of 12 months clinical outcomes associated with implantation of ultrathin (60MM) Bare metal stent in an unselected real world population with coronary artery disease: Journal of clinic and diagnostic research 2014 May vol-11(5): Oct 12-oct-16.
    • Review article: Individualization of hypertension treatment: An expert review: International journal of advance in medicine garg.R. Int j adv med 2023 aug 10(8).
    • Significance of ambulatory and home blood pressure mounitoring in hypertension management: An Indian perpective: International journal of advanced research in medicine 2023, d (3) 14-17.
    • Guideline – directed medical therapy in the management of cardiovascular disease: A cross sectional questionaire based study amongst Indian health care professionals: Journal of clinical and diagnostic, research 2025 apr. VOL19 (4) OC06-OC11.
    • Optimizing screening strategies for hypertension in India: A consensus statement: Journal of the association of physicans of India (2025): 10.59556/Japi.73.0926.
    • Delevered lecture at makonal state level conference.

    Special Interests

    • Interventional cardiology
    • Structural heart disease (Asd, pda, vsd closer, tavi)
    • Heart failure clinic and transplant specialist
    • Htn, pacemaker clinic, prothetic valve clinic

    Could not find what you are looking for? 

    Request a Callback

    Image
    Image
    Request A Call Back
    Request Type